logo-loader

Arch Therapeutics, Inc.

Receive alerts
Market:
OTCQB
Market Cap:
$46.4 m
Price
0.25 USD
Change
6.03%
52 weeks high
0.44
52 weeks low
0.12

In brief

Arch Therapeutics, Inc. (Arch), formerly Almah, Inc engaged in developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding and seal wouds. The Company is a medical device company offering an elegant and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care.